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Objective: The durability of carotid endarterectomy (CEA) may be affected by carotid
restenosis. The data from randomized trials show that the highest incidence of resteno-
sis after CEA occurs from 12 to 18 months after surgery. The optimal CEA technique
to reduce perioperative complications and restenosis rates is still undefined. This study
examines the long-term clinical outcome and incidence of recurrent stenosis in patients
who undergo eversion CEA. Previously published perioperative results of this study did
not show statistically significant differences in study endpoints between the eversion and
standard techniques.
Methods: From October 1994 to March 1997, 1353 patients with surgical indications for
carotid stenosis were randomly assigned to undergo eversion (n = 678) or standard CEA
(n = 675; primary closure, 419; patch, 256). Withdrawal from the assigned treatment
occurred in 1.6% of the patients (in 13 assigned to eversion CEA, and in nine assigned
to standard CEA). The clinical and duplex scan follow-up examination was 99% com-
plete, and the mean follow-up interval was 33 months (range, 12 to 55 months). The
primary outcomes were perioperative and late major stroke and death, carotid resteno-
sis (stenosis ≥ 50% of the lumen diameter detected at duplex scanning), and carotid
occlusion. The primary evaluation of study outcomes was conducted on the basis of an
intention-to-treat analysis.
Results: Restenosis was found at duplex scanning in 56 patients (19 in the eversion
group, and 37 in the standard group). Within the standard group, the restenosis rates
were 7.9% in the primary closure population and 1.5% in the patched population. Of the
patients with restenosis, 36% underwent cerebral angiography that confirmed restenosis
in all cases. The cumulative restenosis risk at 4 years was significantly lower in the group
that underwent treatment with eversion CEA as compared with the standard group
(3.6% vs 9.2%; P = .01), with an absolute risk reduction of 5.6% and a relative risk reduc-
tion of 62%. Eighteen patients would have had to undergo treatment with eversion CEA
to prevent one restenosis during the 4-year period. The incidence rate of ipsilateral
stroke was 3.3% in the eversion population and 2.2% in the standard group. There were
no significant differences in the cumulative risks of ipsilateral stroke (3.9% for eversion,
and 2.2% for standard; P = .2) and death (13.1% for eversion, and 12.7% for standard;
P = .7)) in the two groups. Of the 18 variables that were examined for their influence
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on restenosis, eversion CEA (hazard ratio, 0.3; 95% confidence interval, 0.2 to 0.6; P =
.0004) and patch CEA (hazard ratio, 0.2; 95% confidence interval, 0.07 to 0.6; P =
.002) were negative independent predictors of restenosis with multivariate Cox propor-
tional hazards regression analysis.
Conclusion: The EVEREST (EVERsion carotid Endarterectomy versus Standard Trial)
showed that eversion CEA is safe, effective, and durable. No statistically significant dif-
ferences were found in late outcome between the eversion and standard techniques at the
available follow-up examination. (J Vasc Surg 2000;31:19-30.)
study in seven Italian centers with high case loads of
carotid surgery and prior experience in eversion
CEA. The exclusion criteria were emergent CEA,
redo CEA, CEA simultaneous with coronary bypass
grafting surgery or peripheral vascular surgery, and
poor life expectancy. In the case of bilateral CEA,
only one artery was randomized. Patient consent was
obtained before randomization. The method of cere-
bral monitoring for the detection of clamping
ischemia (local anesthesia, electroencephalography,
transcranial Doppler scan, stump pressure, soma-
tosensory evoked potentials) and the criteria for
shunting were left to the discretion of the surgeon.
Randomization was carried out with a computer-
generated list that was prepared for each site by the
coordinating center. The patients were allocated to
eversion or conventional CEA through sequentially
numbered sealed envelopes that contained informa-
tion on the surgical technique to be applied. The
patients were considered to be eligible for random-
ization only when the intraoperative assessment
results revealed feasibility for both conventional and
eversion CEA. After surgery, the patients underwent
assessment at regular intervals scheduled at 1, 6, and
12 months and then yearly thereafter for 4 years.
Each follow-up visit consisted of a duplex scan
examination and clinical evaluation.
Outcome events. The primary endpoints were
early and late postoperative carotid restenosis or
occlusion and major stroke and death. Carotid
occlusion, stroke, and death were defined as early
when occurring within 30 days of surgery and as late
when occurring later. Restenosis was defined as early
if it occurred within 2 years of surgery. Carotid
restenosis was defined as a reduction of at least 50%
of the operated vessel as detected with postoperative
duplex scan examination. The degree of restenosis
was determined with the measurement of the peak
systolic velocity, end diastolic velocity, and degree of
spectral broadening as previously described.5
The underlying causes of death and severity of
strokes were assessed. The postoperative strokes
were considered to be major if the patients had a
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Randomized trials have evaluated the advantage
of carotid endarterectomy (CEA) in patients with
moderate, severe, symptomatic, or asymptomatic
carotid stenosis.1-4 Yet, the surgical techniques that
are available for this type of operation and their
repercussions on the durability of the procedure
have received less attention. In an era in which the
endovascular procedures are becoming of age, every
surgical approach to the carotid artery should be
analyzed to provide alternatives to carotid percuta-
neous transluminal angioplasty (PTA) and thus to
undertake the optimal treatment strategy.
Eversion CEA prevents the longitudinal arteri-
otomy of the internal carotid artery, provides optimal
correction of an elongated internal carotid artery,
and has been associated with low restenosis rates.5-14
The EVEREST (EVERsion carotid Endarterectomy
versus Standard Trial) was designed to evaluate the
feasibility and durability of eversion CEA.
The durability of CEA may be affected by carotid
restenosis. The optimal CEA technique to reduce
perioperative complications and restenosis rates is
still undefined. This report provides data on the late
outcome and restenosis rates of 1353 patients who
were randomly assigned to eversion or conventional
CEA between October 1994 and March 1997. The
perioperative results were previously published and
did not show statistically significant differences
between the two surgical techniques in terms of
stroke/death and early restenosis rates.5
PATIENTS AND METHODS
The details of the trial design and research meth-
ods have been previously reported.5 Between
October 1994 and March 1997, 1353 patients with
carotid stenosis who required surgical treatment
were randomly assigned to undergo conventional (n
= 675; primary closure, 419; patch, 256) or eversion
CEA (n = 678). A Dacron graft patch was used in
213 procedures, a polytetrafluoroethylene graft in
29, and a saphenous vein graft in 14.
Eligibility, randomization, and follow-up
examination. The patients were recruited to the
Rankin score of 3 or more.15 Disability was evaluat-
ed before surgery, at 1 and 6 months after surgery,
and at each subsequent follow-up examination. In
June 1996, the Safety and Monitoring Committee
introduced a simple validated questionnaire to sim-
plify the assessment of disability.16
A primary analysis of all study outcomes was
conducted on an intention-to-treat basis.
The secondary endpoints were minor stroke, tran-
sient ischemic accident, and myocardial infarction.
Statistical analysis. The trial was designed to
confirm a 4.7% difference in the restenosis rate
between eversion and standard CEA at 3 years (on
the basis of a previous study14), with an α of 0.05
and a power of 0.80. The required recruitment was
1200 patients, with a follow-up period of 4 years.
Because the treatment effect was found before the
scheduled interval, we herein report trial results at a
minimum follow-up period of 2 years. Patient fol-
low-up examination will continue as scheduled.
Should significant differences be found relative to
the results reported here, they will be published in a
subsequent report.
Eversion and standard CEA were compared with
primary intention-to-treat analysis on the basis of
time of treatment failure by life-table curves. Benefit
of treatment was described in terms of relative and
absolute reductions in restenosis and major stroke
risk and number of patients needed to undergo
treatment to prevent one outcome event within 4
years of the procedure. In the primary analysis,
carotid restenosis and ipsilateral stroke were consid-
ered to be treatment failures. Different endpoints
were considered in secondary analysis: all strokes,
deaths, and strokes according to severity (major or
minor). P values below .05 were considered to be
statistically significant.
The influences of 18 baseline, anatomic, and sur-
gical factors in the determination of restenosis were
investigated with Cox proportional hazards regression
analysis (age, shunt, gender, smoking, clamping time,
diabetes, hypertension, patch CEA, operating sur-
geon, eversion CEA, collaborating center, hypercho-
lesterolemia, peripheral vascular disease, preoperative
antiplatelet treatment, contralateral carotid occlusion,
intraoperative technical defects, carotid plaque exten-
sion ≥ 2 cm, and carotid diameter < 4 mm).
The influences of 24 baseline, anatomic, and sur-
gical factors in determining ipsilateral stroke were
investigated with Cox hazard regression models (age,
shunt, gender, smoking, clamping time, diabetes,
hypertension, patch CEA, tandem lesions, eversion
CEA, operating surgeon, collaborating center, atrial
fibrillation, hypercholesterolemia, peripheral vascular
disease, coronary artery disease, restenosis ≥ 50%, pre-
operative cerebral symptoms, contralateral carotid
occlusion, preoperative antiplatelet treatment, carotid
plaque extension ≥ 2 cm, carotid diameter < 4 mm,
intraoperative detected technical defects, and preop-
erative brain infarct on computed tomographic scan
or magnetic resonance imaging).
RESULTS
The trial profile is reported in Fig 1. A total of
1353 patients with carotid stenosis who required
surgical treatment were randomly allocated to ever-
sion (n = 678) or standard (n = 675) CEA (Fig 1).
Withdrawal from the assigned treatment occurred in
1.6% of the patients (13 assigned to eversion CEA,
and nine to standard CEA). The mean follow-up
period was 33 months (range, 12 to 55 months).
Only three patients were lost to follow-up examina-
tion, two because of emigration. However, they
were included in the analysis until they were lost to
follow-up examination (two patients at 27 months,
and one at 12 months). Eight patients died within 1
month of surgery, and one patient had early carotid
occlusion within 30 days of the procedure,5 which
left 1344 patients available for the evaluation of
restenosis—671 in the eversion group, and 673 in
the standard CEA group. Complete duplex scan
data of the operated carotid artery during the fol-
low-up period was available in 99.5% of the patients
(Fig 1).
There were eight perioperative deaths (0.5%):
three from ischemic stroke, one from hemorrhagic
stroke, two from myocardial infarction, and two
from cardiopulmonary arrest. Twenty-eight periop-
erative strokes were reported. Incidence rates of
perioperative primary and secondary endpoints have
been previously reported.5 The incidence rates of
the primary and secondary endpoints in the two
study groups after 30 days of surgery are reported in
Table I. Late death occurred in 118 patients. The
causes of late death included fatal stroke in 15
patients, cardiac death in 41 patients, cancer in 20
patients, and other causes in 42 patients. Late stroke
occurred in 33 patients—15 in the eversion group,
and 18 in the standard group. Only in one case did
stroke appear to be related to the occlusion of an
operated carotid artery. No significant differences in
the neurologic outcomes were found between the
two study groups.
As reported in Table I, 56 restenoses (4.2%) were
found at a mean follow-up period of 33 months: 19
(2.8%) in the eversion group, and 37 (5.5%) in the
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standard group, according to intention-to-treat
analysis (odds ratio [OR], 0.5; 95% confidence inter-
val [CI], 0.3 to 0.9; P = .02). Similarly, on-treatment
analysis results (on the basis of treatment actually
undergone) showed a 2.7% restenosis rate in the
eversion group versus a 5.6% rate in the standard
group (OR, 0.46; 95% CI, 0.3 to 0.9; P = .01).
Arteriographic assessment of restenosis was avail-
able in 36% of the patients (20 of 56 patients). In 55
cases (98%), restenosis was silent. Only one patient
had ipsilateral stroke subsequent to restenosis.
Overall, 18 restenoses were corrected (seven in the
eversion group, and 11 in the standard group): three
patients underwent carotid PTA, 12 PTA and stent-
ing, and three a second CEA with patch. The sever-
ity of restenosis is reported in Table II. Ninety-five
percent of restenosis (n = 53) occurred within 2
years of the procedure: 19 in the eversion group,
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Fig 1. Trial profile. Restenosis rate at mean follow-up period of 33 months. Patients lost to
follow-up examination: four patients at 6 months, three patients at 12 months, two patients at
24 months, and two patients at 36 months.
* Withdrawn from assigned treatment but in follow-up examination for intention-to-treat
analysis.
Table I. Incidence rates of primary and secondary endpoints in 1353 patients after 30 days
Eversion CEA Standard CEA 
(n = 678) (n = 675)
No. % No. % P value OR 95% CI
A. Late primary endpoints
Death 55 8.1 63 9.3 .4 0.8 0.6-1.3
Vascular death 24 3.5 30 4.4 .4 0.8 0.4-1.4
Major stroke 9 1.3 14 2.1 .3 0.6 0.2-1.6
Ipsilateral major stroke 4 0.6 2 0.3 .6 2 0.3-22.1
Restenosis ≥ 50%* 19 2.8 37 5.5 .02 0.5 0.3-0.9
Restenosis ≥ 50%† 18 2.7 38 5.6 .01 0.46 0.3-0.9
B. Late secondary endpoints
Ipsilateral TIA 2 0.3 5 0.7 .2 0.4 0.04-2.4
Minor stroke 6 0.8 4 0.6 .7 1.5 0.4-7.3
Ipsilateral minor stroke 5 0.7 1 0.1 .2 5 0.6-237.2
Myocardial infarction 35 5.2 36 5.3 .9 1 0.6-1.6
C. Stroke (major + minor) 15 2.2 18 2.6 .7 0.8 0.4-1.8
Ipsilateral stroke (major + minor) 9 1.3 3 0.4 .1 3.01 0.8-17.4
CEA, Carotid endarterectomy; OR, odds ratio; CI, confidence interval; TIA, transcient ischemic attack.
*Intention-to-treat analysis: detected only in patients with duplex scan follow-up examination (eversion, n = 671; standard, n = 673).
†On-treatment analysis: detected only in patients with duplex scan follow-up examination (eversion, n = 668; standard, n = 676).
and 34 in the standard group. The life-table esti-
mates of the cumulative risk of restenosis at 4 years
were 3.6% in the eversion CEA group and 9.2% in
the standard CEA group (with log-rank test, P =
.01; Fig 2). The relative and absolute restenosis risk
reductions that compared eversion and standard
CEA and the number of patients needed to undergo
treatment to prevent one restenosis within 4 years of
the procedure are reported in Table III. There were
no significant differences in cumulative risks of ipsi-
lateral stroke (3.9% for eversion, and 2.2% for stan-
dard CEA; P = .2) and death (13.1% for eversion,
and 12.7 for standard CEA; P = .7 ) in the two
groups (Figs 3 and 4).
Of the 18 variables that were examined for their
influence on restenosis, eversion CEA was a negative
independent predictor of restenosis on multivariate
Cox proportional hazards regression analysis (hazard
ratio, 0.3; 95% CI, 0.2 to 0.6; P = .0004). Because
patch was used only in the standard group, initially
three statistical models to analyze the role of patch
on restenosis had been applied: one with the variable
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 1, Part 1 Cao et al 23
Fig 2. Cumulative percentage of patients free of restenosis at 4 years in eversion and standard
groups.
Table II. Severity of restenosis in 1344 patients
Eversion CEA Standard CEA 
(n = 671) (n = 673)
Restenosis No. % No. %
50% to 69% 8 1.2 19 2.8
70% to 99% 9 1.3 17 2.6
100% 2 0.3 1 0.1
Total 19 2.8 37 5.5
CEA, Carotid endarterectomy.
Table III. Restenosis actuarial rate at 4 years
Ever- Stan-
sion dard P ARR RRR
% % value (%) (%) NNT
Restenosis ≥ 50%* 3.5 9.1 .01 5.6 62 18
Restenosis ≥50%† 3.4 9.2 .006 5.8 63 17
ARR, Absolute risk reduction; RRR, relative risk reduction;
NNT, number needed to treat.
*Intention-to-treat analysis: detected only in patients with duplex
scan follow-up examination (eversion, n = 671; standard, n = 673).
†On-treatment analysis: detected only in patients with duplex scan
follow-up examination (eversion, n = 668; standard, n = 676).
patch, one without the variable patch, and one with
the variable patch x primary closure (ie, an interac-
tion between patch and primary closure was applied).
No relevant differences were observed between the
three models, although all confirmed patch as a neg-
ative independent predictor of restenosis. We herein
report the statistical model, including the variable
patch (Cox proportional hazards regression analysis,
JOURNAL OF VASCULAR SURGERY
24 Cao et al January 2000
Fig 3. Cumulative percentage of patients free of ipsilateral stroke at 4 years in eversion and
standard groups.
Fig 4. Cumulative survival rates at 4 years in eversion and standard groups.
forward stepwise logistic regression; hazard ratio,
0.2; 95% CI, 0.07 to 0.6; P = .002).
Of the 24 variables that were examined for their
influence on ipsilateral stroke, technical defects
detected during surgery (hazard ratio, 2.5; 95% CI,
1.1 to 5.7; P = .02), need of shunt (hazard ratio,
3.9, 95% CI, 1.9 to 7.6; P = .0001), and the pres-
ence of an ischemic lesion on preoperative comput-
ed tomographic scan or magnetic resonance imaging
(hazard ratio, 2.4; 95% CI, 1.3 to 4.7; P = .007)
were positive independent predictors of ipislateral
stroke, whereas CEA with patch was a negative inde-
pendent predictor of ipsilateral stroke (hazard ratio,
0.3; 95% CI, 0.09 to 0.99; P = .04) on Cox propor-
tional hazards regression analysis.
Subgroup analysis. The patients in the EVER-
EST were randomized to eversion or standard CEA
(primary closure or patch). After assignment to the
standard group of the trial, the choice of patch or
primary closure CEA was left to the discretion of the
surgeon and not to randomization. The results of
the subanalysis of the eversion (n = 678), patch (n =
256), and primary closure (n = 419) procedures
have been compared separately for incidence of
restenosis and ipsilateral stroke.
When CEAs with patch were compared with pri-
mary closure procedures alone, the restenosis rates
were 1.5% (4 of 256) and 7.9% (33 of 415), respec-
tively (OR, 0.2; 95% CI, 0.05 to 0.5; P = .0008).
When eversion CEA was compared with patch pro-
cedures alone, the restenosis rates were not statisti-
cally significant: 2.8% (19 of 671) versus 1.5% (OR,
0.54; 95% CI, 0.1 to 1.7; P = .38). The restenosis
rates between eversion and primary closure subsets
were 2.8% versus 7.9% (OR, 0.34; 95% CI, 0.2 to
0.6; P = .0002).
The life-table estimates of the cumulative risk of
restenosis at 4 years in eversion, patch, and primary
closure were 3.5%, 1.7%, and 12.6%, respectively. The
comparison between the eversion and the patch CEA
actuarial restenosis rates was not statistically signifi-
cant (with log-rank test, P = .3; Fig 5). Conversely,
the comparisons of eversion versus primary closure
and patch versus primary closure revealed a statistical
significant difference (with log-rank test, P = .0002
and P = .0008, respectively; Fig 5).
The life-table estimates of the cumulative risk of
ipsilateral stroke between eversion, patch, and pri-
mary closure were 3.9%, 1.2%, and 2.6%, respective-
ly. No statistically significant differences were found
in the comparison of cumulative risk of ipsilateral
stroke (eversion vs patch, P = .1; eversion vs prima-
ry closure, P = .6; patch vs primary closure, P = .2;
Fig 6).
DISCUSSION
The EVEREST trial was designed to evaluate the
feasibility and durability of eversion CEA. This is the
first trial performed in a large population to assess
the role of eversion CEA in carotid surgery.
Extensive applicability and safety in the short term
along with a good performance in the long term
could be shown for the eversion technique. This was
documented with encouraging stroke/death rates,
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 1, Part 1 Cao et al 25
Fig 5. Cumulative risk of restenosis at 4 years in eversion (EVER), patch, and primary closure
(PC) procedures.
low incidence of technical defects,5,17 and restenosis
associated with eversion CEA.
We previously reported on the early performance
and on the technical defects of eversion CEA in the
EVEREST trial.5,17 Herein, we report on the dura-
bility of the technique. Restenosis is a quite complex
event, mainly because its natural history is still
unclear. The Asymptomatic Carotid Atherosclerosis
Study (ACAS) database provided data on the inci-
dence and timing of restenosis after CEA, defined as
a more than 60% reduced carotid diameter on
duplex scanning. Among the 591 patients who were
available for postoperative follow-up examination,
an overall restenosis rate of 12.7% was found. With
respect to timing, the highest incidence rate of
restenosis was found in the time interval between 
3 and 18 months after surgery (7.6%), whereas
between 18 and 60 months after surgery the inci-
dence rate dropped to 1.9%. The remaining inci-
dences occurred within 3 months of surgery.18
Although the ACAS and EVEREST differ signifi-
cantly in study design, population (only asympto-
matic carotid stenoses were randomized in the
ACAS), and definition of restenosis, it is reasonable
to assume that, in the EVEREST population, the
majority of restenoses have already occurred.
A variety of studies on restenosis have been con-
ducted, with results that vary considerably in the dif-
ferent experiences with respect to incidence, symp-
toms, and management.18-29 In an extensive review
article, Lattimer and Burnand30 examined the histo-
ry, incidence, etiology, and pathology of recurrent
carotid stenosis. The authors reported an overall
incidence rate of symptomatic restenosis that ranged
from 0 to 8.2% and a symptom-free recurrence rate
between 1.3% and 37%. Forty-three of 55 studies
that were examined indicated that revisional surgery
was performed on patients with symptoms, and only
21 of 55 studies indicated that operations were car-
ried out on asymptomatic patients. This review is
indicative of how controversial the management of
this problem is and of how different the incidence
rate of restenosis is among different centers. In the
EVEREST population, restenosis was an infrequent
event and rarely responsible for neurologic symp-
toms. Of the 56 patients in the trial with restenosis,
only one had an ipsilateral stroke subsequently.
However, other studies have documented that half
of late ipsilateral strokes after CEA may be related to
recurrent carotid stenosis.18,19
Besides possible clinical repercussions, restenosis
represents a problem even if asymptomatic. It con-
fronts the surgeon with considerable problems,
including appropriateness and method of interven-
tion, more intensive patient care, and patient anxi-
ety. Eversion CEA can alleviate this problem, thus
representing an appealing alternative. In particular,
patients in the EVEREST who underwent eversion
CEA were three times less likely to have a restenosis
during the follow-up period than were their coun-
terparts who underwent standard CEA (patch and
primary closure).
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Fig 6. Cumulative percentage of patients free of ipsilateral stroke at 4 years in the eversion
(EVER), patch, and primary closure (PC) population.
In line with other reports,18,31-39 the EVEREST
confirmed the positive role of CEA with patch in the
reduction of recurrent stenosis. In particular, Moore
et al,18 in reporting the ACAS experience, found
that the use of patch angioplasty was the single fac-
tor that was associated with a reduction in the rate
of recurrent stenosis on multivariate analysis.
In this regard, the data from the EVEREST
regarding patch and primary closure procedures,
although not evidenced based, may be of interest to
the reader and therefore have been included. Yet, it
should be emphasized that, in early 1994, when
EVEREST was designed, the intention of the inves-
tigators was to analyze the early performance and
durability of eversion CEA versus endarterectomy
procedures different from eversion CEA. For this
reason, a two-arm trial was designed comprising the
eversion and standard groups—the latter including
patch and primary closure procedures together, the
choice of which was left to the discretion of the sur-
geon. The trial sample size determination was made
on the basis of a difference in incidence of restenosis
between the eversion and standard groups. No cal-
culation of events in patch CEA alone had been esti-
mated. Thereby, the figures on the performance of
CEA with patch and primary closure, if considered
separately in our study, would be burdened by selec-
tion biases, thus detracting from the significance of
the results. In particular, the EVEREST includes
678 patients who underwent eversion CEA, 419
who underwent primary closure, and only 256 who
underwent patch CEA.
With respect to patch and eversion CEA, it is rea-
sonable to speculate that, in some instances, eversion
CEA may be more beneficial in that it is associated
with reduced clamping times,5 it avoids the use of
prosthetic material, which is a possible source of infec-
tion, and it allows the correction of kinking and coil-
ing. Surely, eversion is only one of the possible
approaches to carotid stenoses in need of surgical cor-
rection. Other surgical possibilities have proven effec-
tive, yet eversion CEA may represent an option in spe-
cific instances also to surgeons familiar with different
CEA techniques. In this regard, it should be stressed
that the surgeons who participated in this trial were
selected for their high level of expertise and for their
previous experience with the eversion technique for
CEA. In the majority of the partcipating centers in the
trial, more than 200 CEAs are performed each year. If
the participating centers of this study had not been
selected, different results would have likely emerged
and the satisfactory outcomes from the application of
eversion CEA may not have been as evident.
In conclusion, the EVEREST showed that ever-
sion CEA, performed by an experienced surgeon, is
safe, effective, and durable. Patch CEAs procedures,
although performed on a minority of the study pop-
ulation, showed a durability that was equivalent to
eversion CEA.
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DISCUSSION
Dr John J. Ricotta (Stony Brook, NY). I would like to
congratulate Dr Cao on a nice presentation. He and his col-
leagues have presented the midterm results of the EVEREST
trial, which is a prospective randomized comparison of ever-
sion and standard carotid endarterectomy. The trial is well
designed, the endpoints are clear, and the analysis is appro-
priate. Crossover occurred in less than 2% of patients, and
the long-term follow-up examination results are excellent.
The current report compares outcomes after a mean
follow-up period of 33 months. As stated, there was a sig-
nificant increase in restenosis when standard endarterecto-
my with primary closure was compared with both eversion
endarterectomy and patch closure. There was no differ-
ence in restenosis between eversion endarterectomy and
conventional endarterectomy with patch closure. All but
one restenosis was asymptomatic, and only one third of
restenoses were corrected.
I agree that surgeons should do everything possible to
reduce the incidence of restenosis in what is essentially a
prophylactic operation. Zero tolerance should be the goal.
Eversion endarterectomy and standard endarterectomy
with patch closure appear to be equivalent in this regard.
My first question is whether you believe that there is
any current role for conventional endarterectomy with pri-
mary closure given your results and those of other ran-
domized studies?
You note in your manuscript that all of your surgeons
were experienced in the eversion technique before begin-
ning this study. In my more limited experience of 20 or so
cases, I found the technique to be challenging in cases
with extensive plaque, particularly when the plaque
extends well into the common carotid artery. Also, deter-
mining an endpoint in the internal carotid may be difficult
at times. Therefore, I have several technical questions.
How long is the learning curve with this operation?
Are there certain cases that are not suited for this tech-
nique, such as those with extensive plaque either high in
the internal carotid artery or well down into the common
carotid artery?
How often must this technique be abandoned in favor
of bypass grafting or a conversion to standard endarterec-
tomy with patch?
I have found insertion of a shunt cumbersome in these
cases, and I have avoided the technique when I anticipate
shunt use. What are your tricks to insert the shunt, which
I note was done in about 17% of your cases?
What kind of quality control do you use to ensure a
good distal endpoint in the internal carotid artery?
The potential advantage of this technique is the place-
ment of the suture line in the carotid bulb rather than in
the internal carotid artery. When restenosis occurred in
your eversion cases, where was it located?
Was this different in location from restenosis in a stan-
dard endarterectomy?
Do you have any insight as to the cause of restenosis
in the eversion patients?
I believe this trial has established the safety and effica-
cy of the eversion technique. It has shown it is superior to
primary closure and equivalent to conventional endarterec-
tomy with patch closure. Personally, I am not convinced
that there is sufficient benefit of this method to prompt me
to switch to its routine use, and I have found it difficult in
certain circumstances. However, I believe this is a tech-
nique that should be learned by every carotid surgeon
because it is particularly useful in the management of
redundant carotid arteries and is easily performed in focal
lesions of the bifurcation.
Again, I would like to congratulate Dr Cao and his
colleagues for an excellent presentation, and I would like
to thank the Societies for the privilege of the podium.
Dr Piergiorgio Cao. Thank you, Dr Ricotta, for your
stimulating comments. You raised several questions that I
will try to answer.
Concerning conventional carotid endarterectomy with
primary closure, my personal opinion is that it should be lim-
ited when you have very short plaque on the internal carotid
artery and arteriotomy can be limited to the bulb. This is my
personal opinion. There are no data about this in the trial.
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Regarding the learning curve, all the participating
centers had a high caseload of carotid endarterectomy and
quite a large previous experience with the eversion tech-
nique. I agree that one of the most critical points is the
plaque extending on the common carotid artery that
makes you extend the arteriotomy proximally toward the
heart. Exact tailoring of the transected internal carotid
artery can be difficult in the first phase of this technique.
According to the protocol, we always did a completion
study after the procedure. We had an 8% intraoperative-
detected defect rate. In three cases, eversion endarterecto-
my had to be converted to bypass grafting.
About the shunt, although in many cases in the trial
the shunt was used, I agree that the shunt is quite cum-
bersome to insert. We usually fully evert the internal
carotid artery, take the plaque out, and then insert the
shunt. It takes 1 to 2 minutes.
We have no data about the location of restenosis.
Unfortunately, this information was not included in the fol-
low-up examination form. We are planning to review our 56
restenoses to evaluate where the restenoses occurred.
As for the cause of restenosis, as I already stated, we
did the completion study in 96% of the patients, so we can
presume that all the restenoses were caused by intimal
hyperplasia, not to residual defects.
Thank you again for your comments.
Dr Gary M. Gross (Huntsville, Ala). Many surgeons
perform eversion endarterectomy without transection of the
artery. With standard longitudinal arteriotomy, not extend-
ing beyond the proximal, bulbous origin of the internal
carotid artery, and with some gentle traction on the mobi-
lized distal internal carotid artery, it is not difficult to evert
8 to 10 mm of plaque, visualize the endpoint, and tack it
down if necessary. In our experience, this usually achieves
complete plaque removal to a healthy intima, with the
exception of some patients with plaque much higher. The
Cooley transverse technique is another way of everting.
How high in the internal carotid artery was the endpoint in
your cases of transection/eversion? On the basis of that dis-
tance, or on the basis of your general impression, do you
think in the majority of cases that eversion for 1 cm without
transection would achieve a good result or would your
higher eversion lead to a more complete endarterectomy?
Dr Cao. With full transection of the internal carotid
artery, we can go beyond 2 cm cranially. Be careful to dis-
sect the internal carotid artery, then you can easily reach
the endpoint most of the time. In our experience, the end-
point is not a very challenging problem because it can
almost always be reached. The best way to avoid any prob-
lem is to visualize the endpoint in doing a full eversion of
the transected internal carotid artery.
Dr M. Ashraf Mansour (Maywood, Ill). I have two
questions for you.
The first is whether you have to tack the endpoint on
your internal carotid artery? And if you do, how do you do
that?
And the second is what do you do with the external
carotid artery?
Dr Cao. This is an important question. In the trial, we
never had to tack the distal endpoint in the eversion
carotid endarterectomy group because we always visual-
ized the endpoint.
About the external carotid artery, this is a critical
point. Sometimes, after completion angiography, we
found a defect on the external carotid artery. Sometimes it
is not easy to reach an endpoint in the side. In that case,
we just clamp the origin of the external carotid artery,
open longitudinally, take off the flap, and close it.
Dr George S. Lavenson, Jr (Visalia, Calif). This paper
continues the search for a method of carotid endarterecto-
my that can lower the perioperative stroke rate as close to
zero as possible. We have also found, as the first discussant
from the floor pointed out, that there is a method that can
achieve the advantage of the eversion technique without
the transection of the internal carotid artery. When carotid
endarterectomy is performed with local anesthesia, a shunt
is not required in approximately 95% of cases, and, in these
cases, the surgeon can keep the upper end of the arterioto-
my below the end of the lesion in the wide, proximal inter-
nal carotid artery. The upper end of the lesion can then be
freed from within and removed, after which the intima
inside is meticulously cleaned with fine forceps with loop
magnification to the endpoint. This technique avoids the
extension of the arteriotomy into the narrow, higher por-
tion of the internal carotid artery and decreases the risk of
postoperative thrombosis and the need to patch, but with-
out the transection of the artery. If one is not sure that the
endpoint is pristine, the arteriotomy can be extended, a
good endpoint assured, and a patch used if needed.
Dr Cao. I agree that this technique can be useful. We
sometimes use it. I addressed this issue in my answer to Dr
Ricotta.
Dr Kenneth C. Grant (Charlottetown, Prince Edward
Island, Canada). Dr Cao, these operations look nice on
duplex scan after the surgery. Another way of looking at
how nice of an operation you are doing, I think, is the
early systolic velocities in the endarterectomy site. We
measured those and found that there was quite a marked
difference in favor of the eversion technique. Have you
done that early, and have you looked at comparison in a
statistical way of the early systolic velocities at the
endarterectomy site for the two procedures?
Dr Cao. As far as the intraoperative completion studies
are concerned, in the trial, most of the time we did
angiography and angioscopy. We did not do any duplex
scan studies during surgery.
I do not have any data on the first duplex scan control,
which was done at 1 month. But I can review these data
later on to check whether there is any difference in peak
systolic velocity between the two techniques.
Dr Robert M. Blumenberg (Schenectady, NY).
Sometimes after detaching the internal carotid artery, you
find that the plaque in the common carotid artery is more
extensive than you thought before you detached it. In evalu-
ating your restenoses, did you find a large percentage of them
at the proximal terminal point at the common carotid artery
level or were they primarily internal carotid artery restenoses?
Dr Cao. As I said, I think the common carotid artery
plaque is a critical point in this technique. We do not have
data yet on the location of restenosis, but we certainly plan
to review our 56 patients with restenosis to locate exactly
where the restenoses are.
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